Literature DB >> 7075023

Role of antibody in the protection of mice from arthritis induced by Mycoplasma pulmonis.

E C Keystone, A J Cunningham, A Metcalfe, M Kennedy, P A Quinn.   

Abstract

C3H and C57Bl10 mice exhibit a differential susceptibility to arthritis induced by Mycoplasma pulmonis. Resistant C57Bl10 mice consistently demonstrated higher complement-fixing antibody titres than susceptible C3H mice throughout the development of the acute arthritis. A strong correlation was demonstrated between the levels of anti-mycoplasma antibody and resistance to acute arthritis in six strains of mice. To test the hypothesis that the difference of arthritis resistance of C3H and C57Bl10 mice was caused by a different susceptibility of their lymphocytes to mitogenic stimulation by M. pulmonis, we investigated the generation of non-specific immunoglobulin in vivo and in vitro. M. pulmonis acted as a polyclonal mitogen, but stimulated approximately equal responses in lymphocytes of both strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075023      PMCID: PMC1536526     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Mycoplasma pneumoniae is a polyclonal B-cell activator.

Authors:  G Biberfeld; E Gronowicz
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

2.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

3.  Antibody coated erythrocytes as a manifold probe for antigens.

Authors:  G A Molinaro; S Dray
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

4.  Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis.

Authors:  G Taylor; D Taylor-Robinson; G Slavin
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

5.  Observations on the arthritogenic properties of Sabin's type C murine mycoplasma (Mycoplasma histotropicum).

Authors:  P C Hannan
Journal:  J Gen Microbiol       Date:  1971-08

6.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

7.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

8.  Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice.

Authors:  B C Cole; L Golightly-Rowland; J R Ward
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Arthritis in mice due to infection with Mycoplasma pulmonis. II. Serological and histological features.

Authors:  H J Harwick; A D Mahoney; G M Kalmanson; L B Guze
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

10.  Experimental arthritis in mice with Mycoplasma pulmonis.

Authors:  J A Barden; J G Tully
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

View more
  4 in total

1.  Monoclonal antibodies that inhibit mitogenic activity of Mycoplasma pulmonis.

Authors:  Z Lapidot; R Siman-Tov; Y Naot
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

2.  Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis.

Authors:  B Evengård; K Sandstedt; G Bölske; R Feinstein; I Riesenfelt-Orn; C I Smith
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

3.  Toxicity but not arthritogenicity of Mycoplasma arthritidis for mice associates with the haplotype expressed at the major histocompatibility complex.

Authors:  B C Cole; R N Thorpe; L A Hassell; L R Washburn; J R Ward
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

4.  Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response.

Authors:  J S Williamson; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.